Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Large B-Cell, Diffuse × acalabrutinib × Clear all

Phase

Phase 2 9 Phase 1/2 2 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 11 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, B-Cell 1 Leukemia 1 Hematologic Diseases 1

Interventions

Rituximab 61 Cyclophosphamide 43 Doxorubicin 38 Vincristine 37 Prednisone 33 Etoposide 17 Radiotherapy 13 Gemcitabine 13 Lenalidomide 11 Cytarabine 11 Peripheral Blood Stem Cell Transplantation 10 Filgrastim 10 Oxaliplatin 9 Carmustine 9 VAP-cyclo protocol 8 Prednisolone 8 Melphalan 8 Mitoxantrone 5 Methotrexate 5 Ifosfamide 5 Bleomycin 5 polatuzumab vedotin 4 R-CHOP protocol 4 Injections 4 Cyclosporine 4 pegfilgrastim 3 ibritumomab tiuxetan 3 Vindesine 3 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05820841 2023-08-31

ARCHED

Universität des Saarlandes

Phase 3 Recruiting

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡